Literature DB >> 30073510

Validation of sodium/glucose cotransporter proteins in human brain as a potential marker for temporal narrowing of the trauma formation.

Sabrina Oerter1, Carola Förster2, Michael Bohnert3.   

Abstract

In many forensic cases, the existence of a traumatic brain injury (TBI) is an essential factor, and the determination of the survival time is nearly as important as the determination of whether or not a trauma exists. Since it is known that glucose uptake increases in injured brain cells in order to perpetuate the neuronal integrity, this study focuses on the pathomechanism of brain glucose supply via sodium/glucose cotransporters 1 and 2 (SGLT1, SGLT2) following traumatization. Human cerebrum tissue of male and female individuals who died following TBI was taken from the contusional and contralateral regions, as well as from individuals deceased due to cardiac arrest (control group). Total SGLT1 and SGLT2 protein expression was analyzed by immunoblotting comparing injured and non-injured tissue. The immunoreactivity in contusional cerebral cortex region began to increase 3 to 7 h following traumatization. We found that both SGLT1 and SGLT2 protein expression increased significantly 37 h post-injury compared to the control group. SGLT1 rose significantly at 52 h post-injury and peaked significantly at 72 h, while SGLT2 rose significantly at 52 and 72 h after injury. By compiling these data, we predict a standard operator via SGLT expression as a comparative expression assertion to determine post-injury survival time for unknown cases. Our result suggests that SGLT1 and SGLT2 protein expression may be useful in forensic practice as an effective target to analyze the existence of a TBI and to determine the time of the traumatization.

Entities:  

Keywords:  Biomarker; Human; Post-mortem; SGLT; Sodium-glucose transporters; Traumatic brain injury

Mesh:

Substances:

Year:  2018        PMID: 30073510     DOI: 10.1007/s00414-018-1893-6

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  11 in total

1.  Updating the risk profile of fatal head trauma: an autopsy study with focus on age- and sex-dependent differences.

Authors:  Katharina Kronsbein; Bernd Karger; Jan Budczies; Heidi Pfeiffer; Daniel Wittschieber
Journal:  Int J Legal Med       Date:  2019-11-18       Impact factor: 2.686

2.  Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial.

Authors:  Stephanie Kullmann; Julia Hummel; Robert Wagner; Corinna Dannecker; Andreas Vosseler; Louise Fritsche; Ralf Veit; Konstantinos Kantartzis; Jürgen Machann; Andreas L Birkenfeld; Norbert Stefan; Hans-Ulrich Häring; Andreas Peter; Hubert Preissl; Andreas Fritsche; Martin Heni
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

3.  Analysis of the risk of traumatic brain injury and evaluation neurogranin and myelin basic protein as potential biomarkers of traumatic brain injury in postmortem examination.

Authors:  Yanjie Shang; Yuxin Wang; Yadong Guo; Lipin Ren; Xiangyan Zhang; Shujuan Wang; Changquan Zhang; Jifeng Cai
Journal:  Forensic Sci Med Pathol       Date:  2022-02-24       Impact factor: 2.456

Review 4.  Glucose transporters in brain in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-13       Impact factor: 3.657

5.  Metabolomics in postmortem cerebrospinal fluid diagnostics: a state-of-the-art method to interpret central nervous system-related pathological processes.

Authors:  Benjamin Ondruschka; Michael Bohnert; Simone Bohnert; Christoph Reinert; Stefanie Trella; Werner Schmitz
Journal:  Int J Legal Med       Date:  2020-11-12       Impact factor: 2.686

6.  TMEM119 as a specific marker of microglia reaction in traumatic brain injury in postmortem examination.

Authors:  Simone Bohnert; Anja Seiffert; Stefanie Trella; Michael Bohnert; Luitpold Distel; Benjamin Ondruschka; Camelia-Maria Monoranu
Journal:  Int J Legal Med       Date:  2020-07-27       Impact factor: 2.686

7.  Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats.

Authors:  Kenji Takeda; Hiraku Ono; Ko Ishikawa; Tomohiro Ohno; Jin Kumagai; Hidetoshi Ochiai; Ai Matumoto; Hidetaka Yokoh; Yoshiro Maezawa; Koutaro Yokote
Journal:  BMJ Open Diabetes Res Care       Date:  2021-04

8.  Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury.

Authors:  Benjamin Ondruschka; Michael Bohnert; Simone Bohnert; Christoph Wirth; Werner Schmitz; Stefanie Trella; Camelia-Maria Monoranu
Journal:  Int J Legal Med       Date:  2021-04-24       Impact factor: 2.686

Review 9.  Glucose, Fructose, and Urate Transporters in the Choroid Plexus Epithelium.

Authors:  Yoichi Chiba; Ryuta Murakami; Koichi Matsumoto; Keiji Wakamatsu; Wakako Nonaka; Naoya Uemura; Ken Yanase; Masaki Kamada; Masaki Ueno
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

10.  Sodium/glucose cotransporter 2 is expressed in choroid plexus epithelial cells and ependymal cells in human and mouse brains.

Authors:  Yoichi Chiba; Yasunori Sugiyama; Nozomu Nishi; Wakako Nonaka; Ryuta Murakami; Masaki Ueno
Journal:  Neuropathology       Date:  2020-06-02       Impact factor: 1.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.